Literature DB >> 24745663

Bladder cancer: a portal into men's health.

Sean C Skeldon1, S Larry Goldenberg2.   

Abstract

Bladder cancer is the fourth most common cancer among men in the United States, with a 3-fold higher incidence than women. Globally, tobacco smoking remains significantly more common in men, contributing to half of all cases of bladder cancer. To prevent bladder cancer, urologists should promote smoking cessation to patients presenting at earlier ages with concerns such as sexual dysfunction, infertility, pelvic pain, or vasectomy. Bladder cancer also provides an entry point for men into the healthcare system, at which time, urologists can discuss and coordinate attention to other male health issues such as cardiovascular illness, depression, or addiction. By assuming the role of men's health physicians, urologists can have a significant benefit on men's urologic and overall health by targeting risk factors and behaviors.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bladder cancer; Men׳s Health; Smoking

Mesh:

Year:  2014        PMID: 24745663     DOI: 10.1016/j.urolonc.2013.12.005

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  8 in total

1.  90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study.

Authors:  Hooman Djaladat; Behrod Katebian; Soroush T Bazargani; Gus Miranda; Jie Cai; Anne K Schuckman; Siamak Daneshmand
Journal:  World J Urol       Date:  2016-10-12       Impact factor: 4.226

2.  microRNA-195 inhibits cell proliferation in bladder cancer via inhibition of cell division control protein 42 homolog/signal transducer and activator of transcription-3 signaling.

Authors:  Cheng Zhao; Lin Qi; Minfeng Chen; Longfei Liu; Weiqian Yan; Shiyu Tong; Xiongbing Zu
Journal:  Exp Ther Med       Date:  2015-07-09       Impact factor: 2.447

3.  miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.

Authors:  Wei Huang; Cheng Zhang; Shida Xiong; Xiaocheng Zhou; Gongxian Wang; Ju Guo
Journal:  Discov Oncol       Date:  2022-07-01

4.  A novel cell-free single-molecule unique primer extension resequencing (cf-SUPER) technology for bladder cancer non-invasive detection in urine.

Authors:  Cheng Zhao; Yi Pan; Yinhuai Wang; Yuanwei Li; Weiqing Han; Li Lu; Wei Tang; Pei Li; Zhenyu Ou; Mengda Zhang; Zhuang Xiong; Ran Xu; Qiang Lu; Zhenzhou Xu; Lin Qi; Long Wang; Genming Xu
Journal:  Transl Androl Urol       Date:  2020-06

5.  LncRNA DANCR regulates lymphatic metastasis of bladder cancer via the miR-335/VEGF-C axis.

Authors:  Qinrong Ping; Yunqiang Shi; Meng Yang; Hui Li; Yiming Zhong; Jian Li; Xiaofang Bi; Chunhui Wang
Journal:  Transl Androl Urol       Date:  2021-04

6.  MicroRNA-124 inhibits cell proliferation, invasion and migration by targeting CAV1 in bladder cancer.

Authors:  Wandan Zhou; Leye He; Yinbo Dai; Yichuan Zhang; Jinrong Wang; Bin Liu
Journal:  Exp Ther Med       Date:  2018-07-30       Impact factor: 2.447

7.  Diabetes Is a Risk Factor for the Prognosis of Patients with Bladder Cancer: A Meta-Analysis.

Authors:  Lv Dong; Xiang Ying; Song Tao; Zhou Guang-Peng; Shen Tai-Ming
Journal:  J Oncol       Date:  2022-09-26       Impact factor: 4.501

8.  Matrine Restrains Cell Growth and Metastasis by Up-Regulating LINC00472 in Bladder Carcinoma.

Authors:  Linlin Li; Fei Qi; Kaichen Wang
Journal:  Cancer Manag Res       Date:  2020-02-18       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.